Construction	O
of	O
recombinant	B:C1510800
adenovirus	I:C1510800
Ad-rat	I:C1510800
PLCγ2	I:C1510800
and	O
its	O
effects	O
on	O
apoptosis	B:C0162638
of	O
rat	B:C0034693
liver	B:C0227525
cell	I:C0227525
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
in	B:C3850137
vitro	I:C3850137
.	O

Although	O
the	O
role	O
of	O
PLC	B:C0662760
γ	I:C0662760
2	I:C0662760
in	O
apoptotic	O
response	B:C0243095
has	O
been	O
reported	O
,	O
too	O
little	O
is	O
known	O
about	O
whether	O
PLC	B:C0662760
γ	I:C0662760
2	I:C0662760
induces	O
liver	B:C0227525
cell	I:C0227525
apoptosis	B:C0162638
during	O
liver	B:C0023907
regeneration	I:C0023907
.	O

Therefore	O
,	O
this	O
study	B:C2603343
firstly	O
packaged	O
Ad	B:C1510800
-	I:C1510800
PLC	I:C1510800
γ2	I:C1510800
recombinant	I:C1510800
adenovirus	I:C1510800
and	O
primarily	O
evaluated	O
its	O
effect	O
on	O
apoptosis	B:C0162638
of	O
rat	B:C0034693
liver	B:C0227525
cell	I:C0227525
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
in	B:C3850137
vitro	I:C3850137
.	O

Following	O
ten	O
days	O
of	O
co-transfection	B:C0040669
of	O
pHBAd-MCMV-GFP	B:C0032136
-PLCγ2	I:C0032136
and	O
pHBAd-BHG	B:C0032136
into	O
HEK293	B:C2936239
cells	I:C2936239
,	O
viral	B:C0010827
cytopathic	I:C0010827
effect	I:C0010827
(	O
cytopathic	B:C0333467
effect	I:C0333467
)	O
was	O
apparent	O
.	O

Following	O
three	O
rounds	O
of	O
amplification	O
,	O
tissue	O
culture	O
infectious	O
dose	O
50	O
(	O
TCID50	O
)	O
assay	B:C1510438
showed	O
that	O
the	O
titer	O
value	O
reached	O
1×1010	O
PFU	O
/	O
mL	O
.	O

After	O
24	O
h	O
of	O
transfection	B:C0040669
of	O
recombinant	B:C1510800
adenovirus	I:C1510800
into	O
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
cells	I:C0227525
,	O
transfection	B:C0040669
efficiency	O
of	O
adenovirus	B:C0001483
into	O
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
cells	I:C0227525
was	O
above	O
90	O
%	O
when	O
obsereved	O
under	O
fluorescent	B:C0026022
microscopy	I:C0026022
.	O

qRT-PCR	B:C1514628
and	O
Western	B:C0005863
blot	I:C0005863
assays	I:C0005863
showed	O
mRNA	B:C0035696
and	O
protein	B:C0428479
levels	I:C0428479
of	O
PLC	B:C0662760
γ2	I:C0662760
were	O
significantly	O
elevated	O
in	O
the	O
transfected	B:C0040669
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
cells	I:C0227525
.	O

Flow	B:C0200904
cytometric	I:C0200904
analysis	I:C0200904
showed	O
that	O
,	O
compared	O
with	O
the	O
control	O
and	O
Ad-	B:C1510800
GFP	I:C1510800
groups	I:C1510800
,	O
cell	B:C0162638
apoptosis	I:C0162638
rate	O
of	O
Ad-	B:C1510800
PLC	I:C1510800
γ	I:C1510800
2	I:C1510800
group	I:C1510800
were	O
significantly	O
increased	O
(	O
P<	O
0.01	O
)	O
,	O
and	O
the	O
cell	B:C0007586
cycle	I:C0007586
in	O
Ad	B:C1510800
-	I:C1510800
PLC	I:C1510800
γ	I:C1510800
2	I:C1510800
group	I:C1510800
was	O
arrested	B:C1155873
at	O
G1	O
phase	O
which	O
was	O
manifested	O
by	O
a	O
marked	O
increase	O
(	O
P<	O
0.01	O
)	O
in	O
the	O
percentage	O
of	O
G1	O
phase	O
cells	B:C0007634
and	O
a	O
great	O
decrease	O
(	O
P<	O
0.01	O
)	O
in	O
the	O
percentage	O
of	O
S	O
and	O
G2	O
/	O
M	B:C1450044
phase	I:C1450044
cells	B:C0007634
.	O

It	O
was	O
concluded	O
from	O
above	O
results	B:C0456984
that	O
recombinant	B:C1510800
adenovirus	I:C1510800
Ad	I:C1510800
-	I:C1510800
PLCγ2	I:C1510800
was	O
packaged	O
successfully	O
,	O
and	O
could	O
promote	O
cell	B:C0162638
apoptosis	I:C0162638
by	O
arresting	B:C1155873
the	O
transition	B:C1516334
from	O
G1	O
to	O
S	O
phase	O
of	O
BRL	B:C0227525
-	I:C0227525
3A	I:C0227525
cells	I:C0227525
.	O

